The patient disposition is presented in Figure S1 . The final analysis population was 340 patients, comprised of the 260 patients in the recovered group and 80 patients in the persistent worsening group. Patients with censored-only events were excluded from the analysis.
Figure S1. Patient Disposition Patient Characteristics ny Symptom-Defined Exacerbation Status
Patients in the study sample (N=340) were similar to those with no symptom-defined events in terms of age, gender, race, airflow obstruction, history of acute exacerbations, and other baseline characteristics (Table S1 ). Study inclusion criteria ensured all patients had moderate to severe COPD, a history of ≥ 1 HCRU event in the last 12 months, and were symptomatic at the time of enrollment. 
Exact Scores Over Time
Group mean EXACT scores by recovery group during the run-in period through the end of the study are presented in Figure S2 . The persistent worsening group had consistently lower group mean EXACT scores than the recovered patients up until approximately Day 28 (corresponding to the median time to first event) when their scores increased in an exacerbation event and remained elevated for the remainder of the study period.
Figure S2. Mean EXACT Scores Over Entire Study Period (Days -14 to 84) by Recovery Group
Higher scores are worse.
Recovered Group n=260; Persistent Worsening Group n=80
Health Status and Lung Function Change Over Time
Change scores in SGRQ and FEV1 from baseline to Week 12 are summarized in Table S2 . The proportion of patients in each group whose health status improved, did not change, or deteriorated was also compared across recovery groups, with groups defined by SGRQ total score thresholds for clinically meaningful change. Between-group differences in SGRQ total and symptoms scores were statistically significant. No differences in lung function deterioration or the proportion of patients who improved, did not change or deteriorated was identified. p-values based on student's t-test or χ
